Imatinib mesylate in the treatment of chronic myeloid leukemia: a local experience
This study was done to assess the overall response rate of imatinib mesylate in local patients with chronic myeloid leukaemia. A total of 69 patients were recruited with male/female ratio of 7:3. Of the 69 patients; 35% were in the chronic phase, 41% were in the accelerated phase, 17% were in blast...
Saved in:
Main Authors: | , , , |
---|---|
Format: | Article |
Published: |
Malaysian Medical Association
2006
|
Subjects: | |
Online Access: | http://eprints.um.edu.my/12019/ http://www.e-mjm.org/2006/v61n5/Chronic_Myeloid_Leukemia.pdf |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|